文献速递衰弱、肌少症与跌倒老年慢病共病管理

加速功能促进疗法开发的协同策略:曲速行动与肿瘤药物开发的经验

Synergistic Strategies to Accelerate the Development of Function-Promoting Therapies: Lessons From Operation Warp Speed and Oncology Drug Development.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2023-01-01

本文为专家小组讨论,总结曲速行动和肿瘤药物开发经验,认为功能促进疗法开发需多方利益相关者协作;成功的关键包括明确定义适应症、研究人群和患者重要终点,充足资源分配及灵活组织结构。

要点

  • 功能促进疗法开发需学术、NIH、专业学会、患者组织、产业及FDA等多方协作。
  • 成功试验需明确定义适应症、研究人群和可用验证工具可靠测量的患者重要终点。
  • 需充足资源分配和类似曲速行动的灵活组织结构。

核心结论

  • 功能促进疗法的加速开发是公共卫生优先事项,需多方利益相关者协作。

研究设计与样本

  • 专家小组讨论(Expert panel discussion),未报告样本量。

主要发现

  • 曲速行动在COVID-19疫苗和治疗药物快速开发方面的显著成功以及过去十年肿瘤药物开发项目的经验可供借鉴。
  • 复杂公共卫生问题如功能促进疗法开发需要学术研究者、NIH、专业学会、患者及患者倡导组织、制药和生物技术产业以及FDA等协作。

关键数值与推荐

  • 成功且把握度充足的临床试验需仔细定义适应症、研究人群和患者重要终点。
  • 终点需能用验证工具可靠测量,并需要 commensurate resource allocation 和灵活的组织结构。

临床怎么用

  • 临床开发功能促进疗法时可参考曲速行动和肿瘤药物开发中的多方协作与组织模式。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Functional limitations and physical disabilities associated with aging and chronic disease are major concerns for human societies and expeditious development of function-promoting therapies is a public health priority. METHODS: Expert panel discussion. RESULTS: The remarkable success of Operation Warp Speed for the rapid development of COVID-19 vaccines, COVID-19 therapeutics, and of oncology drug development programs over the past decade have taught us that complex public health problems such as the development of function-promoting therapies will require collaboration among many stakeholders, including academic investigators, the National Institutes of Health, professional societies, patients and patient advocacy organizations, the pharmaceutical and biotechnology industry, and the U.S. Food and Drug Administration. CONCLUSIONS: There was agreement that the success of well designed, adequately powered clinical trials will require careful definitions of indication/s, study population, and patient-important endpoints that can be reliably measured using validated instruments, commensurate resource allocation, and versatile organizational structures such as those used in Operation Warp Speed.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Correa-de Araujo R, Evans WJ, Fielding RA, et al. Synergistic Strategies to Accelerate the Development of Function-Promoting Therapies: Lessons From Operation Warp Speed and Oncology Drug Development. J Gerontol A Biol Sci Med Sci. 2023. PMID: 37325963. doi:10.1093/gerona/glad028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。